Gil M. Labrucherie, SVP, COO & CFO at NEKTAR THERAPEUTICS (NKTR), sold 18,734 shares at $13.83 ($258K) on 2021-08-16, disclosed to the SEC on 2021-08-18.
Seasonal sale ($258k) by SVP, COO & CFO — this insider has traded NKTR in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.83 | 7,867 | $109K | 42.1% |
| 2 | $13.83 | 7,867 | $109K | 42.1% |
| 3 | $13.56 | 3,000 | $41K | 15.8% |
| Total | $13.79 avg | 18,734 | $258K | 100% |
| Filing → |
| NKTR | SELL | 2022-05-17 | $138K | — | Filing → |
| RZLT | BUY | 2022-05-09 | $400K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $166K | — | Filing → |